266 results
8-K
EX-5.1
LCTX
Lineage Cell Therapeutics, Inc.
14 May 24
Other Events
4:39pm
are applicable to the subject matter hereof and express no opinion and provide no assurance with respect to any other laws or as to compliance
424B5
LCTX
Lineage Cell Therapeutics, Inc.
14 May 24
Prospectus supplement for primary offering
4:36pm
at this time. There can be no assurance that we will sell any shares under or fully utilize the sales agreement with B. Riley as a source of financing.
We
424B5
7fppko
22 Mar 24
Prospectus supplement for primary offering
4:32pm
8-K
EX-1.1
50nud007qokgq06
22 Mar 24
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-5.1
wmxatujyp 3pkoqy
22 Mar 24
Entry into a Material Definitive Agreement
4:15pm
8-K
EX-5.1
iy4yna1gyp3fsx zgr
6 Feb 24
Lineage Cell Therapeutics Announces $14.0 Million Registered Direct Offering
9:20am
8-K
EX-5.1
7htslr xufnlijx3m810
18 May 23
Other Events
5:26pm